First in Human Trial to Assess the Safety & Efficacy of HemoSystem REBOOT in Patients With Sepsis-induced Immunosuppression

Conditions: Septic Shock Interventions: Device: REBOOT Hemosystem Sponsors: hemotune AG Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Research | Septic Shock